JLE

Hépato-Gastro & Oncologie Digestive

MENU

Therapeutic Drug Monitoring (TDM): towards reasoned and reasonable use Volume 25, supplement 3, Novembre 2018

Figures


  • Figure 1

  • Figure 2

  • Figure 3

  • Figure 4

  • Figure 5

Tables

Authors
CHU Saint-Étienne,
Hôpital Nord,
service de gastro-entérologie,
42000 Saint-Étienne,
France
* Tirés à part

Serum anti-TNF concentration is actually is easy to determine using an ELISA test. In clinical practice, therapeutic drug monitoring can optimise our decision in case of clinical failure (loss of response or primary non response). Conversely, a proactive strategy cannot be suggested in clinical practice actually. In case of discussion on treatment lowering, TDM should be recommended. Others indication and notably post-operative indication has to be analysed.

Licence This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License